UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society

Dierssen, M; Herault, Y; Helguera, P; Martinez de Lagran, M; Vazquez, A; Christian, B; Carmona-Iragui, M; ... Bhattacharyya, A; + view all (2021) Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society. Molecular Syndromology 10.1159/000514437. (In press). Green open access

[thumbnail of Fisher_T21RS 2019 revision clean[88391].pdf]
Preview
Text
Fisher_T21RS 2019 revision clean[88391].pdf - Accepted Version

Download (314kB) | Preview

Abstract

Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and phar­ma­cological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.

Type: Article
Title: Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
Open access status: An open access version is available from UCL Discovery
DOI: 10.1159/000514437
Publisher version: https://doi.org/10.1159/000514437
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Down syndrome, Intellectual disability, Language impairment, Mouse models, Neurodevelopmental disorders, Alzheimer’s disease, Biomarkers, Trisomy 21 Research Society
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > UK Dementia Research Institute
URI: https://discovery.ucl.ac.uk/id/eprint/10129544
Downloads since deposit
38Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item